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Abstract
A wide search for ischemic preconditioning (IPC) mechanisms of cardioprotection identified
the light elicited circadian rhythm protein Period 2 (Per2) to be cardioprotective. Studies on
cardiac metabolism found a key role for light elicited Per2 in mediating metabolic depen-
dence on carbohydrate metabolism. To profile Per2 mediated pathways following IPC of
the mouse heart, we performed a genome array and identified 352 abundantly expressed
and well-characterized Per2 dependent micro RNAs. One prominent result of our in silico
analysis for cardiac Per2 dependent micro RNAs revealed a selective role for miR-21 in the
regulation of hypoxia and metabolic pathways. Based on this Per2 dependency, we subse-
quently found a diurnal expression pattern for miR-21 with higher miR-21 expression levels
at Zeitgeber time (ZT) 15 compared to ZT3. Gain or loss of function studies for miR-21 using
miRNA mimics or miRNA inhibitors and a Seahorse Bioanalyzer uncovered a critical role of
miR-21 for cellular glycolysis, glycolytic capacity, and glycolytic reserve. Exposing mice to
intense light, a strategy to induce Per2, led to a robust induction of cardiac miR-21 tissue lev-
els and decreased infarct sizes, which was abolished in miR-21-/- mice. Similarly, first trans-
lational studies in humans using intense blue light exposure for 5 days in healthy volunteers
resulted in increased plasma miR-21 levels which was associated with increased phospho-
fructokinase activity, the rate-limiting enzyme in glycolysis. Together, we identified miR-21
as cardioprotective downstream target of Per2 and suggest intense light therapy as a po-
tential strategy to enhance miR-21 activity and subsequent carbohydrate metabolism in
humans.
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1. Introduction
The rotation of the earth and associated light / dark cycles are responsible for entrainment of
our circadian system, a dramatic evolutionarily conserved feature affecting uni-cellular organ-
isms to humankind. In the 1970s, researchers began investigating the circadian system in Dro-
sophila melanogaster, which led to the identification of gene loci involved in the cellular ‘clock’
such as Period (Per), an important player in the circadian system [1]. In the early 1980’s a mul-
ticenter analysis of the limitations of infarct size reported circadian periodicity for acute myo-
cardial infarction (MI), with a peak incidence at 9 AM compared to 9 PM [2]. Since then, the
spike in morning MI incidence–after a long period without daylight–has been confirmed
repeatedly [3]. These studies suggest that daylight and light-elicited circadian mechanisms play
an important role in MI etiology. In agreement with this postulation, there is a well-docu-
mented increase of MIs during the darker winter months [4]. Because the onset of MI has a
distinct circadian pattern, it has been suggested that disruption of circadian rhythms may con-
tribute to cardiovascular disease [5].
A hallmark of the mammalian circadian pacemaker is its ability to be entrained (i.e., syn-
chronized) by light [6]. Photic stimuli enter the retina and travel via the retinohypothalamic
tract to the suprachiasmatic nucleus (SCN) in the brain, where the signals are transduced to
the molecular clockwork [7, 8]. Blue wavelengths of light are detected specifically by melanop-
sin receptors in retinal ganglion cells that leads to the transcriptional induction of Per2 in the
SCN and concomitant entrainment. Peripheral tissues display oscillations in Per2 expression
similar to those of the brain [9, 10] and thought to be secreted through neurohormonal signal-
ing molecules [7, 11, 12]. Only light with an intensity >180 LUX is able to synchronize the
human circadian system [13], whereas intense light (>10,000 LUX) is most effective. In fact,
our recent studies found that intense light exposure of mice significantly increased cardiac
Per2 levels which was associated with reduced troponin I levels and smaller infarct sizes in
an in-situ model for myocardial ischemia when compared to room light conditions [10].
Studies in Per2-/- mice showed a lack of lactate production during myocardial ischemia and
the inability to induce glycolytic pathways, a necessary adaptive mechanism during cardiac
ischemia [14–16]. When mice were exposed to intense light, the heart had transcriptional
induction of glycolytic enzymes from wildtype mice but not Per2-/- [10]. These findings im-
plicate intense light elicited cardiac Per2 stabilization in endogenous cardioprotection by
enhancing oxygen efficient glycolysis and thereby rendering the heart more readily available to
withstand ischemia.
Targeting oxygen efficient pathways could be an adaptable strategy for preventing or re-
ducing reperfusion injury during myocardial ischemia in humans. Thus, understanding the
interconnection between micro RNAs, circadian rhythmicity, and cellular metabolism during
myocardial ischemia has the potential to identify new therapeutic strategies of cardioprotec-
tion. While a single micro RNA may target multiple transcripts within a cell type, the contri-
bution of circadian micro RNAs to heart ischemia or metabolism are mostly unknown. To
identify micro RNA-based endogenous cardioprotective pathways during MI, we performed a
screening experiment to study transcriptional changes of Per2 dependent micro RNAs during
cardioprotective ischemic preconditioning (IPC) of the heart. Out of 352 most abundantly
expressed micro RNAs, we identified miR-21 amongst the top Per2 dependent micro RNAs
that may play a role in metabolic and IPC mediated cardioprotection. In fact, computational
analysis revealed a selective role for miR-21 in cardiac ischemia reperfusion injury, hypoxia
[17, 18], and metabolic [19, 20] pathways. miR-21 is located on chromosome 17 and is highly
conserved in many species, including human, rat, mouse, fish and frog. Remarkably and in
line with our findings, miR-21 is one of the most robustly up-regulated miRNAs in hearts after
Per2 dependent miR-21
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IPC [21]. Moreover, IPC-mediated cardiac protection against ischemia/reperfusion injury was
inhibited by knockdown of cardiac miR-21 [22]. Using in vitro, murine in vivo and human
studies, our data suggest miR-21 is a novel downstream target of light and IPC elicited Per2
regulation of cardioprotection and carbohydrate metabolism.
2. Methods
2.1 Mouse experiments
Experimental protocols were approved by the Institutional Review Board (Institutional Ani-
mal Care and Use Committee [IACUC]) at the University of Colorado Denver, USA. They
were in accordance with the NIH guidelines for use of live animals. Before experiments, mice
were housed for at least 4 weeks in a 14/10-h light-dark cycle to synchronize (entrain) the cir-
cadian clock of WT mice to the ambient light-dark cycle. We conducted all mouse experiments
at the same time points (ZT 3, ZT15). To eliminate gender- and age-related variations, we rou-
tinely used 12- to 16-week-old male mice [10, 23].
2.2 Per2-/- mice
Per2-/- or miR-21-/- and controls (C57BL/6J or B6129SF1/J) were obtained from the Jackson
Laboratories [24, 25]. Characterization and validation were performed as described previously.
Homozygous mutant mice are morphologically indistinguishable from their wild-type litter-
mates and both males and females are fertile [10, 23, 25].
2.3 Murine model for cardiac ischemic preconditioning [10, 23, 26–32]
Anesthesia was induced (70 mg/kg body weight i.p.) and maintained (10 mg/kg/h) with
sodium pentobarbital. Mice were placed on a temperature-controlled heated table (RT, Effen-
berg, Munich, Germany) with a rectal thermometer probe attached to a thermal feedback
controller to maintain body temperature at 37˚C. The tracheal tube was connected to a
mechanical ventilator (Servo 900C, Siemens, Germany) with pediatric tubing and the animals
were ventilated with a pressure controlled ventilation mode (peak inspiratory pressure of 10
mbar, frequency 110 breaths/min, positive end-expiratory pressure of 3 mbar, FiO2 = 0.3).
Blood gas analysis revealed normal paO2 (115±15 mmHg) and paCO2 (38±6 mmHg) levels
with our ventilator regime. After induction of anesthesia, animals were monitored with a sur-
face electrocardiogram (ECG, Hewlett Packard, Bo¨blingen, Germany). Fluid replacement was
performed with normal saline, 0.2 ml/h i.v. The carotid artery was catheterized for continuous
recording of blood pressure with a statham element (WK 280, WKK, Kaltbrunn, Switzerland).
Operations were performed under an upright dissecting microscope (Olympus SZX12). Fol-
lowing left anterior thoracotomy, exposure of the heart and dissection of the pericardium, the
left coronary artery (LCA) was visually identified and an 8.0 nylon suture (Prolene, Ethicon,
Norderstedt, Germany) was placed around the vessel. Atraumatic LCA occlusion for IPC stud-
ies was performed using a hanging weight system [26, 33]. Successful LCA occlusion was con-
firmed by an immediate color change of the vessel from light red to dark violet, and of the
myocardium supplied by the vessel from bright red to white, as well as the immediate occur-
rence of ST-elevations in the ECG. During reperfusion, the changes of color immediately dis-
appeared when the hanging weights were lifted and the LCA was perfused again [27–29, 31].
2.4 MicroRNA PCR array
Ischemic preconditioning (4 cycles of 5 min ischemia and 5 min reperfusion) with a final
reperfusion time of 120 minutes was performed in C57BL/6J (The Jackson Laboratory) or
Per2 dependent miR-21
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Per2-/- mice. Heart tissue was snap-frozen with clamps pre-cooled to the temperature of liquid
nitrogen. Micro RNA was isolated with Trizol (Invitrogen) and purified using RT2 qPCR-
Grade miRNA Isolation Kit (SABiosciences-Qiagen). cDNA template was generated using
RT2 miRNA First Strand Kit (SABiosciences-Qiagen). miRNA expression was performed
using RT2 miRNA PCR Array Mouse miFinder (SABiosciences-Qiagen).
2.5 Transcriptional analysis
Total RNA was isolated from human endothelial cells (HMEC-1) or murine heart tissue by
Qiazol Reagent (Qiagen) and chloroform extraction in conjunction with the RNeasy Mini Kit
(Qiagen), following manufacturer’s instructions (SA-Biosciences, Qiagen). MicroRNAs were
isolated by a secondary ethanol precipitation (100%) of eluate from initial lysate centrifugation
through the mini column. MicroRNA elution was quantified by Nanodrop 2000 or Qubit fluo-
rometer 3.0. 100 ng of microRNA eluate was used to make cDNA following the miScript RT II
Kit manufacturer’s instructions (Qiagen). cDNA was diluted to 1 to 5 ng/uL for determining
transcript levels by real-time quantitative PCR (iCycler; Bio-Rad Laboratories Inc.) and follow-
ing manufacturer’s instructions for miScript SYBR Green PCR Kit (Qiagen) [34]. Primer sets
for Mm-miR-21 (miScript Primer Assay, Qiagen, 5’-UAG CUU AUC AGA CUG AUG UUG A),
Hs-miR21 (miScript Primer Assay, Qiagen, 5'-UAGCUU AUC AGA CUG AUG UUG A), Hs-
RNU6-2_11 (miScript Primer Assay, Qiagen, used control cat. no. MS00033740, functional in
human, mouse, rat, dog, rhesus macaque, cow pig, and sheep) were used following manufac-
tures instructions. Primer sets for human or mouse Per2 were QuantiTect Primer Assay, Qia-
gen, cat. no. QT00011207, QT00198366 or Invitrogen sense 5´-ACCTGC TCA ACC TCC TTC
TG-3´, antisense 5´-ACT ACT GCC TGC CCC ACT TT-3´, respectively. Human or mouse
Actb were QuantiTect Primer Assay, Qiagen, cat. no. QT01136772 or Invitrogen sense 5'-
CTA GGC ACC AGG GTG TGA T -3', antisense 5'-TGC CAG ATC TTC TCC ATG TC-3'.
cDNA from mRNA was generated using iScript (Bio-Rad) and transcript levels were deter-
mined by real-time RT-PCR (iCycler; Bio-Rad Laboratories Inc.) [34]. The PCR reactions
contained 1 μM sense and 1 μM antisense oligonucleotides with SYBR Green (Bio-Rad, 170–
8880). Each target sequence was amplified using increasing numbers of cycles of 94˚C for 1
min, 58˚C for 0.5 min, 72˚C for 1 min. Quantification of transcript levels was determined by
real-time RT-PCR (iCycler; Bio-Rad Laboratories Inc.).
2.6 Light exposure in mice
Mice were exposed to intense light (10,000 LUX, Lightbox simulating day light, Uplift Tech-
nologies DL930 Day-Light 10,000 Lux SAD, full spectrum) for 3 h [10] or one week and com-
pared to mice maintained at room light [200 LUX [10]]. Mice were housed in a 14/10-h light-
dark cycle to synchronize (entrain) the circadian clock of WT mice to the ambient light-dark
cycle. We conducted all mouse experiments at same time points (ZT 3, ZT15).
2.7 Isolation of fibroblasts
Heart tissue from C57BL6/J mice was minced and digested using Collagenase Type II solution
(Worthington Biochemical Corporation) at 37˚C, 100 rpm, collecting the supernatant every 10
minutes for 90 minutes and replacing with fresh collagenase solution until heart tissue fully
digested. Fibroblasts were isolated after plating and incubation of the cell suspension in a cell
culture incubator with 5% CO2 for 2 h. 2 h upon plating alive and healthy fibroblasts were
adhered to the dish. After cells reached confluency, cells were exposed to normoxia (21% oxy-
gen) or hypoxia (1% oxygen using preequilibrated media for 6 h [35]) and immediately resus-
pended in Trizol for miRNA analysis.
Per2 dependent miR-21
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Table 1. Per2 dependent micro RNAs during cardiac ischemic preconditioning (IPC). Shown are the 65 differentially regulated and Per2 dependent
micro RNAs identified after IPC treatment of wildtype and Per2-/- mice.
IP regulated FC FC function publication species
mmu-miR-16 4.0278 -1.2311 prevents cardiac hypertrophy J Cell Mol Med. 2015 Mar;19(3):608–19 R
mmu-miR-409-5p 6.9644 1.9053 role in the heart not studied yet
mmu-miR-154 5.6962 1.4241 protect against cardiac dysfunction Sci Rep. 2016 Mar 1;6:22442 M
mmu-miR-326 5.6569 1.9053 role in the heart not studied yet
mmu-miR-24 5.579 1.7291 inhibits cardiomyocyte apoptosis J Cell Mol Med. 2015 Jan;19(1):103–12 M
mmu-miR-27b 5.2054 1.6702 increases angiogenesis heart Vase Cell. 2015 Jun 24;7:6 M
mmu-miR-146a 5.1337 1.9725 inhibits cardiomyocyte apoptosis Mol Ther Nucleic Acids. 2016 Mar 15;5:e296 M
mmu-miR-126-3p 4.7568 -1.1329 role in the heart not studied yet
mmu-miR-25 4.6268 1.2397 protects cardiomyocytes lntJ Mol Sc i. 2015 Mar 10;16(3):5420–33. R
mmu-miR-23b 4.4383 1.7654 upregulated in heart failure Eur J Heart Fail. 2016 Apr 12. H
mmu-miR-186 4.4383 -1.021 diagnosis of unstable angina pectoris Eur Heart J. 2014 Aug 14;35(31):2106–14 H
mmu-miR-191 4.4076 1.3195 biomarkers for Ml Biomed Res Int. 2014;2014:418628 H
mmu-miR-150 4.2871 1.3195 protect against cardiac fibrosis Cell Physiol Biochem. 2016 May 17;38(6):2103–2122 M
mmu-miR-342-3p 4.2281 1.4948 biomarker heart failure Eur J Heart Fail. 2013 Oct;15(10):1138–47 H
mmu-miR-28 4.1411 1.0867 increases cardiomyocyte apoptosis Eur Rev Med Pharmacal Sci. 2015; 19 (5) M
mmu-miR-99a 4.1411 1.1487 prevents cardiac hypertrophy PloS One. 2016 Feb 25;11(2):e0148480 M
mmu-miR-322 4.1125 -1.0867 protects against cardiac dysfunction Biochim Biophys Acta. 2016 Apr;1862(4):611–21 M
mmu-miR-30a 4.084 1.7053 protect against cardiac dysfurnction Mol Cell Biochem. 2013 Jul;379(1–2):1–6 M
mmu-miR-23a 4.084 1.9185 increases cardiac hypertrophy J Bioi Chem. 2012 Jan 2;287(1):589–99 M
mmu-miR-181b 4.0278 1.9053 upregulated in heart failure Eur J Heart Fail. 2016 Apr 12. doi H
mmu-miR-101a 3.9724 1.1567 protects cardiac fibroblasts lntJ Biochem Cell Bioi. 2015 Aug;65: 155–64 R
mmu-miR-505 3.9313 1.1368 regenerative neonatal mouse heart Cell Biochem Biophys. 2014 Sep;70(1):635–42 M
mmu-miR-20a 3.9177 -1.3755 prevents cardiac hypertrophy PloS One. 2013 Nov13;8(11):e79133 R
mmu-miR-199b 3.8637 -1.3755 increases cardiac hypertrophy Cardiovasc Res. 2016 May 15;110(2):258–67 M
mmu-miR-324-5p 3.8106 1.5157 attenuates cardiomyocyte apoptosis Cell Death Dis. 2015 Dec 3;6:e2007 M
mmu-miR-30c 3.7842 1.6818 prevents cardiac hypertrophy Circ Res. 2009 Jan 30;104(2):170–8 M
mmu-miR-208b 3.7064 -2.4116 biomarkers for LV remodling lntJ Mol Sc i. 2014 Apr 4;15(4):5774–88. doi H
mmu-miR-301a 3.6808 -1.5583 role in the heart not studied yet
mmu-let-7d 3.6301 1.3287 role in the heart not studied yet
mmu-miR-582-5p 3.6175 -4.4229 role in the heart not studied yet
mmu-miR-466d-3p 3.5554 -1.1173 role in the heart not studied yet
mmu-miR-155 3.5308 -1.0425 increases cardiac hypertrophy J Am Heart Assoc. 2016 Apr 22;5(4) M
mmu-miR-532-3p 3.4224 1.9931 increases cardiomyocyte apoptosis Cell Death Dis. 2015 Mar 12;6:e1677 M
mmu-miR-30e 3.4105 -1.0644 role in the heart not studied yet
mmu-miR-126-5p 3.3636 -1.0425 role in the heart not studied yet
mmu-miR-350 3.3636 1.1647 increases cardiac hypertrophy Biochim Biophys Acta. 2013 Jan;1832(1) R
mmu-miR-148b 3.3404 1.3566 role in the heart not studied yet
mmu-miR-541 3.3173 1.3947 prevents cardiac hypertrophy Cell Death Dis. 2014 Apr 10;5:e1171 M
mmu-miR-301b 3.3173 -1.1647 role in the heart not studied yet
mmu-miR-181d 3.2944 1.0425 role in the heart not studied yet
mmu-miR-106b 3.2266 -1.2924 role in the heart not studied yet
mmu-miR-151-5p 3.2266 1.0353 prevents arrythm ias in Ml Pl oS One. 2013 Sep 9;8(9):e72985 R
mmu-miR-128a 3.2043 1.6133 role in the heart not studied yet
mmu-miR-425 3.1821 1.4044 regu lates ANP product ion Mol Cell Bioi. 2016 May 16. pii: MCB.01114-15 H
mmu-miR-152 3.1821 1 role in the heart not studied yet
mmu-miR-99b 3.1383 1.7901 role in the heart not studied yet
mmu-miR-22 3.1167 1.4845 Cardioprotective Gene. 2016 Mar 15;579(1):17–22 R
(Continued )
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2.8 Isolation of adult cardiomyocytes [10, 32]
8–12 weeks old C57BL6/J mice were anesthetized and the heart was quickly removed from the
chest cavity and immediately placed in ice-cold KHB buffer. After weighing, the aorta was cannu-
lated and the heart were perfused with Ca2+-free KHB for 3 min followed by 8–12 min perfusion
with Ca2+-free KHB containing collagenase. After perfusion, ventricles were removed, minced
and incubated with the collagenase solution for an additional 3–7 min. The cells were filtered
through a nylon mesh (60 μm) and collected in a 15-ml sterile tube. Myocytes were washed and
calcium was slowly re-introduced in a stepwise fashion. Finally, cells were resuspended in MEM
supplemented with FBS, BDM, penicillin, and ATP and plated on laminin. After healthy myocyte
adhesion to laminin-coated plates, media was exchanged for serum-free MEM and cells were
exposed to normoxia (21% oxygen) or hypoxia (1% oxygen using preequilibrated media for 1 h
[36]) the next day and immediately resuspended in Trizol for miRNA analysis [10].
2.9 Endothelial cells
C57BL/6 mouse primary cardiac endothelial cells were obtained from Cell Biologics (C57-
6024) and handled following manufacturer’s instructions in complete mouse endothelial cell
medium supplemented with VEGF, ECGS, heparin, EGF, hydrocortisone, L-glutamine, antibi-
otic-antimycotic solution, and FBS (M1168). After cells reached confluency, cells were exposed
to normoxia (21% oxygen) or hypoxia (1% oxygen using preequilibrated media for 3 h [37])
and immediately resuspended in Trizol for miRNA analysis.
2.10 Metabolic analysis in miR-21 gain or loss of function
For gain of function experiments, we used a MISSION hsa-miR-21 Mimic (Sigma-Aldrich,
cat. no. HMI0372). The miR-21 Mimic was delivered to human microvascular endothelial
Table 1. (Continued)
IP regulated FC FC function publication species
mmu-miR-467c 3.1167 -1.2924 role in the heart not studied yet
mmu-miR-21 3.0738 -1.5369 IP heart, cardioprotection Cardiovasc Res. 2010 Aug 1;87(3):431–9 M
mmu-miR-872 3.0738 -1.0867 role in the heart not studied yet
mmu-let-7i 3.0738 1.021 role in the heart not studied yet
mmu-miR-18a 3.0738 -1.5692 role in the heart not studied yet
mmu-let-7c 3.0525 1.4743 role in the heart not studied yet
mmu-miR-17 3.0525 -1.257 role in the heart not studied yet
mmu-let-7f 3.0314 -1.366 role in the heart not studied yet
mmu-miR-467e 3.0105 -1.6818 role in the heart not studied yet
mmu-miR-219 2.2974 -4.1411 role in the heart not studied yet
mmu-miR-675-5p 1.9521 3.1932 role in the heart not studied yet
mmu-miR-302c 1.7654 24.4201 role in the heart not studied yet
mmu-miR-742 1.0281 3.9449 role in the heart not studied yet
mmu-miR-216a -1.057 4.4076 role in the heart not studied yet
mmu-miR-343 -3.1711 -1.244 role in the heart not studied yet
mmu-miR-744 -3.3636 -1.014 role in the heart not studied yet
mmu-miR-679 -3.4943 -1.4191 role in the heart not studied yet
mmu-miR-292-3p -5.8159 -1.4743 role in the heart not studied yet
IP = Ischemic Preconditioning, FC = Fold Change.
https://doi.org/10.1371/journal.pone.0176243.t001
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cells (HMEC-1) using DharmaFect I Transfection Reagent (Dharmacon). For loss of function
experiments, we used an anti-miR-21 (Qiagen, MIMAT0000076: 5'UAG CUU AUC AGA CUG
AUG UUG A, MIMAT0004494: 5'CAA CAC CAG UCG AUG GGC UGU, MIMAT0004494:
5'CAA CAC CAG UCG AUG GGC UGU; MIMAT0000076: 5'UAG CUU AUC AGA CUG AUG UUG
A) and a miScript Inhibitor Negative Control (Qiagen, cat. no. 1027271). The anti-miR-21 was
delivered to HMEC-1 using HiPerFect Transfection Reagent (Qiagen). Cells were seeded at a
density of 30,000 cells/well prior to transfection. Cells were synchronized by serum starvation,
followed by glycolytic stress test using a Seahorse Bioanalyzer XF24 per manufacturer’s proto-
col. Our glycolytic stress test protocol was optimized for use in HMECs using final concentra-
tions of 10 mM glucose, 1.0 uM oligomycin, and 50 mM 2-deoxy-D-glucose in XF Assay
Medium (Seahorse Biosciences). The Seahorse Bioanalyzer measures extracellular acidification
rates (ECAR) in live HMECs in response to treatment with these compounds.
2.11 Light exposure humans
We obtained approval from the Institutional Review Board (Colorado Multiple Institutional
Review Board [COMIRB]) for our human studies and prior to these studies we obtained writ-
ten informed consent from each individual. Data presented were from 8 healthy individuals (5
males, 3 females). The average age was 29.5 years old (range 23–41 yo). All but one individual
identified as a caffeine drinker. The average number of hours slept prior to intense light expo-
sure did not differ from the week of intense light exposure (6.4h). Healthy human volunteers
were exposed to 30 minutes of intense light (Square One Wake Up Light, NatureBright, Day-
Light 10,000 Lux) in the morning at 8:30 AM for 5 consecutive days. A blood draw was per-
formed before light exposure on the first day (8:30 AM) and 5 days after light exposure (9.00
AM). Blood was collected in EDTA-plasma tubes and spun at 3,000 rpm for 8 minutes to sepa-
rate plasma. Plasma samples were analyzed for miR-21 levels and PFK (phosphofructokinase)
activity. Light boxes were a generous gift from Joshua Chen, NatureBright.
2.12 Phosphofructokinase (PFK) activity
Phoshpofructokinase activity was measured using a PFK Activity Colorimetric Assay Kit (Bio-
Vision, cat. no. K776-100), adhering to manufacturer’s instructions.
2.13 Data analysis
Data were compared by Student’s t test. Values are expressed as mean (SD) from 3–6 animals/
individual cell experiments or 8 healthy human volunteers per condition. The chosen numbers
per group was based on findings in previous studies and a subsequent samples size analysis.
The studies are designed to be able to reject the null hypothesis that the population means of
the experimental and control groups are equal with probability (power) 0.8. The Type I error
probability associated with this test of this null hypothesis is 0.05. P<0.05 was considered sta-
tistically significant. For all statistical analysis, GraphPad Prism 5.0 software for Windows XP
Fig 1. Studies of miR-21 regulation in wiltype and Per2-/- mice after cardiac ischemic preconditioning. Wildtype
(A) or Per2-/- mice (B) were exposed to cardiac IPC, consisting of 4 x 5 minutes of ischemia followed by 5 minutes of
reperfusion each, followed by a final reperfusion time of 120 min. Heart tissue was snap-frozen with clamps pre-cooled
to the temperature of liquid nitrogen. Total RNA was isolated from murine heart tissue using Qiazol Reagent and
separated into mRNA and miRNA components following manufactures instructions (SA-Biosciences, Qiagen). cDNA
from miRNA was generated using miScript RT II kits (Qiagen) and transcript levels were determined by real-time
RT-PCR (iCycler; Bio-Rad Laboratories Inc.; mean±SD, n = 3).
https://doi.org/10.1371/journal.pone.0176243.g001
Per2 dependent miR-21
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was used. The authors had full access to and take full responsibility for the integrity of the data.
All authors have read and agree to the manuscript as written.
3. Results
3.1 Differential and Per2 dependent regulation of micro RNA miR-21
after ischemic preconditioning (IPC)
Our previously published studies showed abolished cardioprotection by IPC in Per2-/- mice [10].
Based on these studies, we pursued a wide micro RNA screen of cardiac Per2 dependent micro
RNAs (Table 1). Out of 352 micro RNAs analyzed, 186 were regulated in both wildtype and
Per2-/- mice, 65 were only regulated in wildtype and 22 were only regulated in Per2-/- mice. As
shown in Table 1, differential regulation of putative Per2 dependent micro RNAs revealed almost
exclusively cardioprotective pathways. Ingenuity analysis revealed a selective role for miR-21 in
protection from reperfusion injury of the heart. After identification of miR-21 as a potential
downstream target of Per2 mediated cardioprotection, we confirmed a Per2 dependent miR-21
regulation in cardiac tissue from wildtype or Per2-/- mice; while IPC resulted in a 2.4-fold induc-
tion of miR-21 in wildtype mice (Fig 1A), no upregulation was observed in Per2-/- mice (Fig 1B).
Taken together, these data demonstrate that IPC induced Per2 regulates cardiac miR-21.
3.2 Diurnal expression pattern of miR-21 in the murine heart and lung
Considering cardiac miR-21 is regulated in a Per2 dependent manner, and cardiac Per2 has a
diurnal oscillation pattern, we next investigated the expression pattern of this micro RNA over
a 12h period. Hearts from wildtype mice were harvested at Zeitgeber time (ZT) 3 or ZT15.
We found significantly higher cardiac miR-21 expression levels at ZT15 compared to ZT3
(1.8-fold increase from ZT3 to ZT15, Fig 2A). Consistent with our previously published stud-
ies [10], analysis of the same heart tissue confirmed significantly higher cardiac Per2 mRNA
levels at ZT15 compared to ZT3 (29-fold increase from ZT3 to ZT15, Fig 2B). To verify a diur-
nal nature of miR-21 we analyzed another organ in addition to the heart. Indeed, analysis of
lung tissue from these wildtype mice at the indicated times revealed lung miR-21 and Per2
mRNA levels significantly higher at ZT15 than ZT3, which was consistent with our findings in
the heart (lung miR-21 3.7-fold increase and lung Per2 mRNA 6.9-fold increase from ZT3 to
ZT15, respectively, Fig 2C and 2D). Taken together, our studies show that murine miR-21
expression oscillates over the circadian day in heart and lungs (ZT3 vs ZT15, p< 0.05), like Per2
which implies a putative circadian expression pattern of miR-21.
3.3 miR-21 is exclusively upregulated in hypoxic cardiac endothelial cells
After confirming that miR-21 is a Per2 regulated micro RNA with a diurnal expression pattern
in heart and lungs, we next investigated which cardiac cell type expressed miR-21 during con-
ditions of low oxygen availability. Based on previous findings that miR-21 is predominantly
expressed in cardiac fibroblasts [38], we obtained fibroblasts, myocytes or endothelial cells
from wildtype mouse hearts. In fact, analysis of relative miR-21 expression levels indicated an
abundant expression of miR-21 in cardiac fibroblasts when compared to other cardiac cell
Fig 2. Diurnal expression of miR-21 in murine hearts and lungs. Analysis of cardiac (A) or lung (B) mir-21 and Per2 levels from
wildtype mice at Zeitgeber Time (ZT) 3 or ZT15. Total RNA was isolated from murine heart or lung tissue using Qiazol Reagent and
separated into mRNA and miRNA components following manufactures instructions (SA-Biosciences, Qiagen). cDNA from miRNA
was generated using miScript RT II kits (Qiagen) and transcript levels were determined by quantitative real-time RT-PCR (iCycler;
Bio-Rad Laboratories Inc.; mean±SD, n = 3, p<0.05).
https://doi.org/10.1371/journal.pone.0176243.g002
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types (Fig 3A). However, since fibroblasts play a dominant role during remodeling [39] but
not during the acute phase of myocardial ischemia and reperfusion [32], we next exposed iso-
lated murine cardiac fibroblasts, myocytes or endothelial cells to 1% oxygen (hypoxia). As
shown in Fig 3B and 3C, no significant regulation of miR-21 was found in fibroblasts or myo-
cytes upon hypoxia exposure when compared to cells at ambient oxygen levels (normoxia).
However, isolated murine cardiac endothelial cells exposed to hypoxia revealed a robust and
significant upregulation of miR-21 (4.9-fold increase compared to ambient oxygen levels, Fig
3D). Further analysis using human microvascular endothelial cells (HMEC-1) confirmed a
miR-21 upregulation in hypoxia (8.6-fold increase in 1% hypoxia, Fig 3E). Taken together,
while miR-21 is predominantly expressed in cardiac fibroblasts at baseline, only cardiac endothe-
lial cells revealed a significant upregulation of miR-21 upon hypoxia exposure. These data suggest
that endothelial expressed miR-21 plays a critical role during conditions of low oxygen availabil-
ity, such as myocardial ischemia.
3.4 miR-21 is critical for cellular glycolysis, glycolytic capacity, and
glycolytic reserve
After confirming that miR-21 is a hypoxia regulated micro RNA with predominant upregulation
in hypoxic cardiac endothelial cells, we next analyzed the role of miR-21 in known Per2 regu-
lated pathways. Our recent studies found an important role of light elicited Per2 in controlling
glycolysis during myocardial ischemia [10, 12, 23]. To understand a potential role of miR-21 in
glycolysis, we first performed loss of function (LOF) studies using miR-21 inhibitors. Anti-miR-
21 inhibitors were transfected into human microvascular endothelial cells (HMEC-1), a cell line
well characterized for hypoxic, metabolic and Per2 pathways [10]. We first confirmed a knock-
down of miR-21 in HMEC-1s and found a 70% reduction of miR-21 expression (Fig 4A). In
miR-21 knockdown HMEC-1s, we assessed glycolysis, glycolytic capacity, and glycolytic reserve
using a glycolytic stress test and Seahorse Bioanalyzer (Fig 4B). Loss of miR-21 significantly
reduced glycolysis (10.7-fold, Fig 4C), glycolytic capacity (31-fold, Fig 4D) and glycolytic reserve
(31-fold, Fig 4E). In contrast, our gain of function (GOF) studies done by overexpressing a miR-
21 mimic (22-fold overexpression, Fig 4F) significantly increased glycolysis (1.3-fold, Fig 4G
and 4H), glycolytic capacity (1.6-fold, Fig 4I) and glycolytic reserve (2.3-fold, Fig 4J) in HMEC-
1s. Taken together, these studies demonstrate that miR-21 is necessary to maintain glycolysis, criti-
cal for the cell to maximally respond to glycolytic demand (glycolytic capacity), and pertinent for glu-
cose reserves to be available for use through glycolysis beyond baseline (glycolytic reserve).
3.5 miR-21-/- mice have larger infarct sizes in myocardial ischemia and
reperfusion
After confirming that miR-21 was necessary for Per2 regulated pathways such as glycolysis, we
next investigated the role of miR-21 in myocardial ischemia and reperfusion injury. Thus, we
Fig 3. miR-21 expression in different cardiac tissues at baseline and during hypoxia. Fibroblasts or myocytes were isolated from C57BL6/J
mouse hearts and endothelial cells isolated from C57/BL6 mice were purchased from Cell Biologics for analyzing miR-21 expression at baseline or
hypoxic (1% oxygen) conditions. miRNA was isolated using RNeasy Mini Kit (Qiagen), cDNA was generated using miScript RT II kits (Qiagen), and
transcript levels were determined by quantitative real-time RT-PCR (iCycler; Bio-Rad Laboratories Inc.). (A) Relative miR-21 expression levels in
C57BL6/J mouse isolated cardiac fibroblasts, myocytes, and endothelia at baseline (mean±SD, n = 3, not significant). (B) miR-21 expression in
cardiac fibroblasts subjected to normoxia or hypoxia for 6 h (mean±SD, n = 6, not significant). (C) miR-21 expression in cardiac myocytes subjected
to normoxia or hypoxia for 1 h (mean±SD, n = 3, not significant). (D) miR-21 expression in cardiac endothelia subjected to normoxia or hypoxia for 6 h
(mean±SD, n = 6, p<0.05). (E) miR-21 expression in human endothelia (HMEC-1) subjected to normoxia or hypoxia for 6 h (mean±SD, n = 6,
p<0.05).
https://doi.org/10.1371/journal.pone.0176243.g003
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first exposed miR-21-/- or control mice (B6129SF1/J) to myocardial ischemia and reperfusion
injury. As shown in Fig 5A, miR-21-/- mice had significant larger infarct sizes after 60 minutes
of ischemia and 120 min of reperfusion than their littermate controls (miR-21-/-: 68 ± 9% vs.
B6129SF1/J: 53.75 ± 6%). Taken together, these studies show that miR-21 is functional and car-
dioprotective in myocardial ischemia and reperfusion injury.
3.6 Light elicited cardioprotection is abolished in miR-21-/- mice
After confirming a cardio-protective role of miR-21 in myocardial ischemia and reperfusion
injury, we next investigated miR-21 as a potential downstream target of Per2 in myocardial
ischemia and reperfusion injury. Previous studies found light exposure to increase cardiac
Per2 and mimic IPC mediated cardioprotection in a Per2 dependent manner [10]. Based on
our findings that IPC increased cardiac miR-21 in a Per2 dependent manner, we next exposed
wildtype controls or miR-21-/- mice to 3 h of intense light prior to myocardial ischemia and
reperfusion injury as done previously in Per2-/- mice [10]. As shown in Fig 5B and 5C, light
exposure significantly reduced infarct sizes in wildtype controls (Intense light vs. room light:
37.5 ± 6.1% vs. 53.75 ± 6%). However, identical intense light exposure conditions in miR-21-/-
mice failed to induce cardioprotection (Room light vs intense light: 68 ± 9% vs. 70.5 ± 8.3%,
Fig 5D and 5E). Taken together, these data show that intense light mediated cardioprotection is
abolished in miR-21-/- mice and suggest that miR-21 is a downstream target of light elicited Per2
in cardioprotection from myocardial ischemia and reperfusion injury.
3.7 Intense light exposure induces cardiac miR-21
After finding that Per2 dependent miR-21 was critical for Per2 regulated glycolysis or light
elicited cardioprotection, we next extended our in vivo studies to determine if exposing mice
to intense light–a strategy to overexpress cardiac Per2 [10]–induces cardiac miR-21. To test
this, wildtype mice were exposed to one week of intense light at 10,000 lux (14h light/10h dark,
Fig 6A) and compared to room light at 200 lux (14h light/10h dark). Housing mice for one
week at intense light significantly increased cardiac miR-21 (6.1-fold, Fig 6B) when compared
to room light housing. As a control for light treatment we also analyzed Per2 levels and found
a robust and significant induction of cardiac Per2 mRNA levels (4.1-fold, Fig 6C), as observed
in earlier studies on cardiac Per2 protein [10]. Taken together, exposing mice to intense light
increases miR-21 levels in cardiac tissues, like Per2 mRNA, which supports that miR-21 could be
indeed a circadian micro RNA downstream of Per2.
3.8 Intense light exposure increases miR-21 and PFK activity in healthy
human volunteers
After we found intense light regulation of cardiac miR-21, we next pursued studies on light
therapy in healthy human volunteers. In fact, earlier studies found increased Per2 levels in buc-
cal swaps from human volunteers upon light treatment [40]. Thus, we exposed eight healthy
volunteers (3 females, 5 males) to 30 min of intense light therapy from 8:30 until 9:00 AM for 5
Fig 4. Glycolysis in miR-21 gain or loss of function human endothelial cells. (A) Knockdown confirmation in anti-mir-21 (loss
of function, LOF) treated human endothelial cells (HMEC-1). (B-E) Glucose metabolism from control (miScript Inhibitor Neg.
Control, scrambled [SCR]) and anti-mir-21 (LOF) treated HMEC-1. (F) Overexpression in miR-21Mimic (gain of function [GOF])
treated HMEC-1. (G-J) Glucose metabolism from control (miScript miRNA Mimic Neg. Control, SCR) and miR-21Mimic (GOF)
treated human endothelial cells (HMEC-1). Cells were seeded at a density of 100,000 cells/well. Glycolysis assay was performed
using glycolysis stress test kit from Seahorse Biosciences according to manufacturer’s protocol using the XF24 instrument. The
extracellular acidification rate (ECAR) response to glucose, oligomycin and 2-DG was measured (mean±SD, n = 6, p<0.05).
https://doi.org/10.1371/journal.pone.0176243.g004
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days (Fig 6C). Blood was drawn on day one at 8:30 AM before any intense light exposure and
on day 5 at 9:00 AM after intense light exposure. Plasma samples were used to isolate micro
RNAs and to determine miR-21 plasma levels. Five days of intense light therapy significantly
increased miR-21 plasma levels in human subjects (3.5-fold, Fig 6D). Based on findings that
miR-21 overexpression was associated with increased glycolysis in vitro, we next determined
plasma phosphofructokinase activity, the key regulatory enzyme in the glycolytic pathway.
Here, intense light exposure led to a 49% increase of PFK activity (Fig 6E). Taken together, one
week of intense light exposure in human subjects increases miR-21 levels in blood plasma samples
which is associated with increased phosphofructokinase activity.
4. Discussion
In the present study, we pursued identification of microRNAs that could mimic circadian
rhythm protein Period (Per2) mediated cardioprotection. Profiling the Per2 dependent expres-
sion of 352 micro RNAs following cardioprotective ischemic preconditioning (IPC) of the
heart indicated an exclusive role for miR-21. Analysis of three cardiac tissues revealed hypoxia
induced miR-21 predominantly in cardiac endothelial cells. Studies on miR-21 expression
revealed a Per2 dependent and putative circadian profile. Using miR-21 LOF or GOF in
HMEC-1s revealed a critical role of miR-21 for Per2 regulated cellular glycolysis. Studies on
myocardial ischemia and reperfusion injury revealed larger infarct sizes and abolished light
elicited Per2 cardioprotection in miR-21-/- mice. Intense light exposure in mice or humans
increased miR-21 levels and light exposure in humans also increased phosphofructokinase
activity. Taken together, these studies suggest manipulation of miR-21 through intense light or
IPC to increase glycolysis, a potential therapeutic strategy for myocardial ischemia (Fig 7).
While miR-21 is one micro RNA that has a strong involvement in cardioprotective path-
ways such as IPC [22] or metabolic pathways [19], other identified microRNAs could be possi-
ble candidates for Per2 mediated pathways. As such studies on miR-22 (Table 1) found that
exosomes, enriched with miR-22, were secreted by mesenchymal stem cells following cardiac
IPC and mobilized to cardiomyocytes where they reduced their apoptosis due to ischemia. In
addition, while miR-21 was found to play a key role in cardiac IPC [22, 41] or preventing apo-
ptosis in cardiomyocytes [18], long-term elevation of miR-21 may be also be detrimental to
the organ by promoting the development of fibrosis in an acute cardiac allograft transplanta-
tion model [42]. Interestingly, these findings would support the idea that an intact circadian
pattern of circadian proteins with high peaks but also low troughs would be most beneficial. In
fact, studies on sepsis outcomes in rats during constant light or constant darkness conditions
found both conditions to be detrimental [43]. Therefore, light exposure probably needs to be
adapted to the time-of-day where intense light late at night could be more detrimental than
beneficial. In fact, clinical studies in humans have found light at night to disrupt circadian
rhythms and to negatively affect metabolism [44, 45].
Research on circadian microRNAs in the heart has been extremely limited. We propose
miR-21 to be circadian based on a Per2 dependent regulation and findings on a diurnal
Fig 5. Light elicited cardioprotection in wildtype and miR-21-/- mice. (A-E) Mice underwent 60 min of ischemia and 120 min of reperfusion at
room light (200LUX) or after exposure to 3 hours of intense light (10,000 LUX). Infarct sizes were measured by double staining with Evan’s blue and
triphenyl-tetrazolium chloride. Infarct sizes are expressed as the percent of the area at risk (AAR) that underwent infarction. (A) Infarct sizes in
wildtype or miR-21-/- mice at room light conditions (mean±SD, n = 4, p<0.05). (B, C) Infarct sizes in wildtype mice after exposure to intense light for 3
h compared to room light conditions. (mean±SD, n = 4, p<0.05). (C) Representative infarct staining in hearts from wildtype mice exposed to intense
light or room light prior to in situ myocardial ischemia and reperfusion (blue, retrograde Evan’s blue staining; red and white, area at risk; white,
infarcted tissue). (D, E) Infarct sizes in miR-21-/- mice exposed to intense light or room light prior to in situ myocardial ischemia followed by reperfusion
(mean±SD, n = 4, not significant). (E) Representative infarct staining in hearts from miR-21-/- mice exposed to intense light or room light prior to in situ
myocardial ischemia reperfusion (blue, retrograde Evan’s blue staining; red and white, area at risk; white, infarcted tissue).
https://doi.org/10.1371/journal.pone.0176243.g005
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expression pattern like that of Per2. However, high temporal resolution gene expression analy-
sis would be necessary to further support that miR-21 is indeed circadian [46]. In general,
studies on circadian micro RNAs are scarce. However, a recent elegant study on sepsis which
also has been shown to be time of day dependent, discovered miR-155 as circadian micro
RNA with profound effects on circadian function and circadian induction of cytokines by LPS
[47]. If a miR-21 knockdown in mice could have similar effects on circadian function seems
compelling but would need to wait further characterization of period lengths in constant dark-
ness or constant light conditions.
MiR-21 is predominantly expressed in cardiac fibroblasts when compared with other cell
types of the heart [39]. Therefore, it is surprising to find a role for miR-21 in cardioprotection
from acute myocardial ischemia and reperfusion injury. In fact, cardiac fibroblasts are consid-
ered as key therapeutic target in cardiac remodeling [39]. However, during acute myocardial
ischemia and reperfusion other cells types, such as inflammatory cells, myocytes or endothelial
cells are more important. As such, a recent study on adenosine signaling in IPC of the heart
found abolished or dampened cardioprotection by IPC in mice with a tissue specific deletion
of the adenosine A2B receptor in cardiomyocytes or endothelia, respectively. Based on these
observations we exposed primary fibroblasts, cardiomyocytes or endothelial cells from
C57BL6/J mouse hearts to hypoxia and analyzed miR-21 expression. Here we found that miR-
21 was exclusively upregulated during conditions of low oxygen availability, indicating that
endothelial expressed miR-21 is critical during acute myocardial ischemia. In fact, a recent
study on myocardial ischemia and reperfusion injury found protective effects of miR-21 in
endothelial injury, further supporting our findings [48].
The critical role of miR-21 in glycolysis seems surprising. However, it was shown that one
of Per2 mediated mechanisms is controlling transcription as a cofactor [49]. In fact, the tran-
scription factor hypoxia inducible factor 1 alpha (HIF1A) is the key regulator of glycolysis [50]
and studies have shown that Per2 and HIFA are bound together during ischemia of the heart
[10]. Furthermore, miR-21 has also been found to be a HIF1A target gene [18]. Data from
these studies would therefore suggest that Per2-HIF1A complex is responsible for the tran-
scriptional regulation of miR-21 during myocardial ischemia. In line with these findings,
recent studies on miR-21 in small lung cancer cells revealed a similar connection between
miR-21, glycolysis and HIF1A [51]. However how miR-21 controls glycolysis would need fur-
ther mechanistic studies. In addition, while our studies demonstrated more PFK activity in
humans exposed to our intense light protocol, the kinetic of elevated PFK and its downstream
effects are not known. Thus, further studies would need to be done in humans, such as in vivo
labeled tracers, to determine if elevated PFK activity does indeed increase glycolytic flux and
glycolytic reliance. If done, these studies could also help elucidate the length of time PFK activ-
ity is elevated and functional after light exposure.
In our studies, using miR-21 deficient mice, we found significantly increased larger infarct
sizes when compared to controls. In contrast, other studies on miR-21 null mice did not find any
significant differences in infarct sizes during myocardial ischemia and reperfusion injury [52, 53].
Fig 6. Effects of intense light on miR-21 regulation in mice and human subjects. (A-C) Wildtype mice were exposed to
broad spectrum intense light (10,000 lux) for 7 days (LD 14:10) and compared to controls that were maintained at room light
(200 lux, LD 14:10). Total RNA was isolated from murine hearts using Qiazol Reagent and separated into mRNA and miRNA
components following manufactures instructions (SA-Biosciences, Qiagen). cDNA from miRNA was generated using miScript
RT II kits (Qiagen) and miR-21 or Per2 transcript levels were determined by real-time RT-PCR (iCycler; Bio-Rad Laboratories
Inc.; mean±SD, n = 3, p<0.05). (D-F) 7 Healthy human volunteers were exposed to 30 minutes of intense blue light (Square
One Wake Up Light, NatureBright, Day-Light 10,000 Lux) in the morning at 8:30 AM on 5 consecutive days. A blood draw was
performed before light exposure on the first day (8:30 AM) and 5 days after light exposure (9.00 AM). Plasma samples were
analyzed for miR-21 levels and PFK (phosphofructokinase) activity (mean±SD, n = 7, p<0.05).
https://doi.org/10.1371/journal.pone.0176243.g006
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While several differences in methodologies might have contributed to the contrary findings, the
most prominent difference was the ischemia time. In our studies mice were exposed to 60 minutes
of ischemia, while the reported paper used 30 minutes of ischemia. Indeed, others have found
marked differences in cardioprotective mechanisms using different ischemia times [54]. Despite
these contrary findings, other studies have shown a protective role for miR-21 in ischemic precon-
ditioning [55], postconditioning [41], or protection form ischemia and reperfusion injury of the
heart [56], using miR-21 inhibitors or mimetics, supporting our current findings.
Light exposure has been found to increase Per2 and glycolytic enzymes and decrease infarct
size and troponin levels during MI in mice [10]. As such, intense light induction of Per2 regu-
lated cardiac miR-21 is not very surprising. However, intense light therapy in the regulation
of microRNAs has not been described yet. While studies on cardioprotective effects of light
exposure in humans are missing, light induced cardioprotective miR-21 could be one mecha-
nism by which intense light exposure reduced myocardial damage in murine studies [10].
In fact, we found intense light elicited cardioprotection to be abolished in miR-21-/- mice.
Similarly, earlier studies found abolished light elicited cardioprotection in Per2-/- mice [10].
Together, these findings support our hypothesis, that miR-21 is downstream of Per2 and indi-
cate a critical role for miR-21 in light or Per2 mediated cardioprotection. Therefore, thinking
of light as potential therapy could represent a novel strategy in the treatment of myocardial
ischemia by modulation of cardioprotective micro RNAs.
The light exposure system we used in the present human studies was a light box emitting
intense (10,000 LUX) and blue light, since light (melanopsin) receptors are most sensitive to
blue light and therefore most effective in synchronizing circadian rhythms [57]. However, we
did not investigate whether the intensity, the blue light specifically, or both, determined these
changes in miR-21 or PFK. Further studies would be needed to identify which component is
necessary for the therapeutic potential of intense light therapy. Regardless, studies in humans
on seasonal affective disorder found low intense blue light as effective as standard bright light
(10 000 LUX, [58]).
To our knowledge nobody has analyzed human metabolic changes upon intense light ther-
apy yet. The effects of intense light therapy in humans are recognized and already widely used.
As such intense light therapy is used to treat winter depression [59, 60], but also might have
effects on preventing delirium [61] or might improve sleep in general [62, 63]. Our findings
show that intense light significantly increased miR-21 in human plasma samples which was
associated with increased phosphofructokinase activity, the key enzyme of glycolysis. These
findings indicate that our in vitro and murine in vivo findings are translatable into a human
system. More detailed studies on intense light therapy in humans will hopefully help us to fur-
ther dissect those mechanisms. However, it needs to be pointed out that it is unclear if light
activated glycolysis in humans would be indeed cardioprotective as seen in murine studies
[10].
Taken together, using a wide microRNA screen in Per2-/- mice we found cardioprotective
miR-21 to be Per2 dependent. Like Per2, miR-21 was light inducible, mediated light elicited
cardioprotecion and regulated glycolysis in human endothelial cells or in human subjects.
Intense light exposure could therefore present a novel and promising approach to activate car-
dioprotective pathways in humans.
Fig 7. Proposed model of IPC or light induced miR-21 and glycolysis. Both IPC and light can induce Per2 in human or murine tissues. In a
Per2 dependent manner miR-21 and phosphofructokinase (PFK) are transcriptionally induced which finally leads to increased PFK activity,
glycolytic capacity and cardioprotection.
https://doi.org/10.1371/journal.pone.0176243.g007
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